Boston Sci Ends TAVR ‘Duopoly’ Held by Medtronic and Edwards

Boston Sci Ends TAVR ‘Duopoly’ Held by Medtronic and Edwards

Source: 
Medical Devices and Diagnostics Industry
snippet: 

Edwards Lifesciences and Medtronic are no longer the only two companies with an FDA-approved transcatheter aortic valve replacement device. Boston Scientific has now received a nod from FDA for the Lotus Edge.